Correlation Between Jiayin and Pfizer
Can any of the company-specific risk be diversified away by investing in both Jiayin and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jiayin and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jiayin Group and Pfizer Inc, you can compare the effects of market volatilities on Jiayin and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jiayin with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jiayin and Pfizer.
Diversification Opportunities for Jiayin and Pfizer
Very weak diversification
The 3 months correlation between Jiayin and Pfizer is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Jiayin Group and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and Jiayin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jiayin Group are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of Jiayin i.e., Jiayin and Pfizer go up and down completely randomly.
Pair Corralation between Jiayin and Pfizer
Given the investment horizon of 90 days Jiayin Group is expected to generate 2.25 times more return on investment than Pfizer. However, Jiayin is 2.25 times more volatile than Pfizer Inc. It trades about 0.06 of its potential returns per unit of risk. Pfizer Inc is currently generating about 0.02 per unit of risk. If you would invest 437.00 in Jiayin Group on October 5, 2024 and sell it today you would earn a total of 219.00 from holding Jiayin Group or generate 50.11% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 99.63% |
Values | Daily Returns |
Jiayin Group vs. Pfizer Inc
Performance |
Timeline |
Jiayin Group |
Pfizer Inc |
Jiayin and Pfizer Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Jiayin and Pfizer
The main advantage of trading using opposite Jiayin and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jiayin position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.Jiayin vs. Oriental Culture Holding | Jiayin vs. Wisekey International Holding | Jiayin vs. Wah Fu Education |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |